Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate

Canine degenerative myelopathy (DM) is an adult-onset, chronic, progressive neurodegenerative disease reported in multiple canine breeds, including the German Shepherd Dog (GSD). Clinical signs include progressive motor neuron paralysis, which begins in the pelvic limbs and eventually leads to respi...

Full description

Bibliographic Details
Main Authors: Shinichiro Maki, Md Shafiqul Islam, Tomohito Itoh, Masanobu Nurimoto, Akira Yabuki, Yu Furusawa, Hiroaki Kamishina, Yui Kobatake, Tofazzal Md Rakib, Martia Rani Tacharina, Osamu Yamato
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/12/13/1647
_version_ 1797481189258297344
author Shinichiro Maki
Md Shafiqul Islam
Tomohito Itoh
Masanobu Nurimoto
Akira Yabuki
Yu Furusawa
Hiroaki Kamishina
Yui Kobatake
Tofazzal Md Rakib
Martia Rani Tacharina
Osamu Yamato
author_facet Shinichiro Maki
Md Shafiqul Islam
Tomohito Itoh
Masanobu Nurimoto
Akira Yabuki
Yu Furusawa
Hiroaki Kamishina
Yui Kobatake
Tofazzal Md Rakib
Martia Rani Tacharina
Osamu Yamato
author_sort Shinichiro Maki
collection DOAJ
description Canine degenerative myelopathy (DM) is an adult-onset, chronic, progressive neurodegenerative disease reported in multiple canine breeds, including the German Shepherd Dog (GSD). Clinical signs include progressive motor neuron paralysis, which begins in the pelvic limbs and eventually leads to respiratory distress, which may necessitate euthanasia. A common DM-associated mutation is a single nucleotide substitution that causes an amino acid substitution (c.118G>A, p.E40K) in the canine <i>SOD1</i> gene. This <i>SOD1</i> mutation and the clinical progression rate of A/A risk genotype in the Japanese GSD population have not been analyzed before. Therefore, the aim of this study was to determine the frequency of the mutated allele and analyze the clinical progression rate in the Japanese GSD population. We studied 541 GSDs registered with the Japanese German Shepherd Dog Registration Society between 2000 and 2019. Genotyping was performed using real-time PCR with DNA extracted from the hair roots of each dog. The study revealed 330 G/G dogs (61%), 184 G/A dogs (34%), and 27 A/A dogs (5%), indicating a frequency of the mutant allele of 0.220, which are in Hardy–Weinberg equilibrium. We analyzed the clinical signs in A/A dogs with an age limit of 10 years based on information obtained from the dogs’ owners. Of the seven A/A dogs older than 10 years, owners reported DM-related clinical signs, indicating a clinical progression rate of 100%. These results, further genotyping, and thorough clinical examinations of <i>SOD1</i> A/A risk genotype will help control and prevent DM in the Japanese GSD population.
first_indexed 2024-03-09T22:10:57Z
format Article
id doaj.art-fee24fec1ecb4219bed7a60be584524d
institution Directory Open Access Journal
issn 2076-2615
language English
last_indexed 2024-03-09T22:10:57Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj.art-fee24fec1ecb4219bed7a60be584524d2023-11-23T19:32:28ZengMDPI AGAnimals2076-26152022-06-011213164710.3390/ani12131647Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression RateShinichiro Maki0Md Shafiqul Islam1Tomohito Itoh2Masanobu Nurimoto3Akira Yabuki4Yu Furusawa5Hiroaki Kamishina6Yui Kobatake7Tofazzal Md Rakib8Martia Rani Tacharina9Osamu Yamato10Laboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanLaboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanMaebashi Institute of Animal Science, Livestock Improvement Association of Japan, Inc., 316 Kanamaru, Maebashi 371-0121, JapanMaebashi Institute of Animal Science, Livestock Improvement Association of Japan, Inc., 316 Kanamaru, Maebashi 371-0121, JapanLaboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanKagoshima University Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanJoint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, JapanJoint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, Gifu 501-1193, JapanLaboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanLaboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanLaboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima 890-0065, JapanCanine degenerative myelopathy (DM) is an adult-onset, chronic, progressive neurodegenerative disease reported in multiple canine breeds, including the German Shepherd Dog (GSD). Clinical signs include progressive motor neuron paralysis, which begins in the pelvic limbs and eventually leads to respiratory distress, which may necessitate euthanasia. A common DM-associated mutation is a single nucleotide substitution that causes an amino acid substitution (c.118G>A, p.E40K) in the canine <i>SOD1</i> gene. This <i>SOD1</i> mutation and the clinical progression rate of A/A risk genotype in the Japanese GSD population have not been analyzed before. Therefore, the aim of this study was to determine the frequency of the mutated allele and analyze the clinical progression rate in the Japanese GSD population. We studied 541 GSDs registered with the Japanese German Shepherd Dog Registration Society between 2000 and 2019. Genotyping was performed using real-time PCR with DNA extracted from the hair roots of each dog. The study revealed 330 G/G dogs (61%), 184 G/A dogs (34%), and 27 A/A dogs (5%), indicating a frequency of the mutant allele of 0.220, which are in Hardy–Weinberg equilibrium. We analyzed the clinical signs in A/A dogs with an age limit of 10 years based on information obtained from the dogs’ owners. Of the seven A/A dogs older than 10 years, owners reported DM-related clinical signs, indicating a clinical progression rate of 100%. These results, further genotyping, and thorough clinical examinations of <i>SOD1</i> A/A risk genotype will help control and prevent DM in the Japanese GSD population.https://www.mdpi.com/2076-2615/12/13/1647canine <i>SOD1</i> genedegenerative myelopathydog breedingGerman Shepherd Dogmutant allele frequencydisease prevention
spellingShingle Shinichiro Maki
Md Shafiqul Islam
Tomohito Itoh
Masanobu Nurimoto
Akira Yabuki
Yu Furusawa
Hiroaki Kamishina
Yui Kobatake
Tofazzal Md Rakib
Martia Rani Tacharina
Osamu Yamato
Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
Animals
canine <i>SOD1</i> gene
degenerative myelopathy
dog breeding
German Shepherd Dog
mutant allele frequency
disease prevention
title Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
title_full Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
title_fullStr Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
title_full_unstemmed Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
title_short Molecular Epidemiological Survey for Degenerative Myelopathy in German Shepherd Dogs in Japan: Allele Frequency and Clinical Progression Rate
title_sort molecular epidemiological survey for degenerative myelopathy in german shepherd dogs in japan allele frequency and clinical progression rate
topic canine <i>SOD1</i> gene
degenerative myelopathy
dog breeding
German Shepherd Dog
mutant allele frequency
disease prevention
url https://www.mdpi.com/2076-2615/12/13/1647
work_keys_str_mv AT shinichiromaki molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT mdshafiqulislam molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT tomohitoitoh molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT masanobunurimoto molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT akirayabuki molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT yufurusawa molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT hiroakikamishina molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT yuikobatake molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT tofazzalmdrakib molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT martiaranitacharina molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate
AT osamuyamato molecularepidemiologicalsurveyfordegenerativemyelopathyingermanshepherddogsinjapanallelefrequencyandclinicalprogressionrate